INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹2,430 Cr | ₹2,178 Cr | ₹1,714 Cr | ₹1,579 Cr | ₹1,334 Cr |
What is the latest Total Liabilities ratio of INDOCO REMEDIES ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹2,430 Cr |
Mar2024 | ₹2,178 Cr |
Mar2023 | ₹1,714 Cr |
Mar2022 | ₹1,579 Cr |
Mar2021 | ₹1,334 Cr |
How is Total Liabilities of INDOCO REMEDIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹2,430 Cr | 11.59 | |
Mar2024 | ₹2,178 Cr | 27.03 | |
Mar2023 | ₹1,714 Cr | 8.55 | |
Mar2022 | ₹1,579 Cr | 18.37 | |
Mar2021 | ₹1,334 Cr | - |
Compare Total Liabilities of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹2,552.6 Cr | -0.1% | -12.6% | -26.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹375,388.0 Cr | -2.2% | -8.3% | -13.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,513.0 Cr | -1.1% | -7.3% | 21.6% | Stock Analytics | |
CIPLA | ₹126,733.0 Cr | -0.7% | 1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,292.0 Cr | -0.5% | -4.2% | 4.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,935.0 Cr | -0.5% | -1.1% | -7.7% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | -0.1% |
-12.6% |
-26.9% |
SENSEX | -1.8% |
-1.6% |
-2% |
You may also like the below Video Courses